Harpoon Therapeutics, Inc. EBITDA 2017-2023 | HARP
Harpoon Therapeutics, Inc. ebitda from 2017 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Harpoon Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-66 |
| 2021 | $-112 |
| 2020 | $-49 |
| 2019 | $-58 |
| 2018 | $-27 |
| 2017 | $-16 |
| 2016 | $-11 |
| Harpoon Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-15 |
| 2023-06-30 | $6 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-18 |
| 2022-09-30 | $-11 |
| 2022-06-30 | $-17 |
| 2022-03-31 | $-19 |
| 2021-12-31 | $-20 |
| 2021-09-30 | $-15 |
| 2021-06-30 | $-16 |
| 2021-03-31 | $-61 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-13 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-13 |
| 2019-12-31 | $-14 |
| 2019-09-30 | $-17 |
| 2019-06-30 | $-13 |
| 2019-03-31 | $-14 |
| 2018-12-31 | |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-6 |
| 2017-12-31 | |
| 2016-12-31 | |
